Clinically, XIAP over-expression was significantly associated with tumor size (p = 0.0044), extra-nodal extension (p = 0.0041), poorly differentiated tumor (p < 0.0001), triple negative breast cancer (0.0019) and infiltrative ductal carcinoma subtype (p = 0.002). Here, XIAP is linked to triple-negative breast carcinoma.